Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

Saúl Reyes, Anthony L. Cunningham, Tomas Kalincik, Eva Kubala Havrdová, Noriko Isobe, Julia Pakpoor, Laura Airas, Reem F. Bunyan, Anneke van der Walt, Jiwon Oh, Joela Mathews, Farrah J. Mateen, Gavin Giovannoni

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.

Original languageEnglish
Article number577627
JournalJournal of Neuroimmunology
Volume357
DOIs
Publication statusPublished - Aug 15 2021

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement'. Together they form a unique fingerprint.

Cite this